Plain language summary and patient perspective of the ASCO guideline: management of Stage III NSCLC

Written by Rachel Jenkins; Joanne Walker; Upal Basu Roy

Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline

Future Oncology, our partner journal, has recently published a Plain Language Summary of Publication and patient perspective of the ASCO guidelines on the management of Stage III NSCLC. Abstract What is this summary about? This is a plain language summary of a guideline on the management of Stage III NSCLC. This guideline was written by the American Society for Clinical Oncology (ASCO) and published in the Journal of Clinical Oncology. Why were the guidelines developed? The purpose of the ASCO guideline is to provide recommendations to healthcare professionals in the US including oncologists, surgeons, pathologists, radiologists, and nurses on how...

To view this content, please register now for access

It's completely free